1.The effect of chronic intermittent hypoxia to hypothalamus-pituitary-adrenal axis and growth hormone level in rats during sleep.
Xue-Wei FENG ; Jian KANG ; Zan-Feng WANG ; Wei WANG ; Run-Jiang YU
Chinese Journal of Applied Physiology 2005;21(4):414-417
AIMTo research the effect of intermittent hypoxia during sleep on hypothalamus-pituitary-adrenal (HPA) axis and growth hormone (GH) level.
METHODSRats were respectively exposed to intermittent hypoxia, room air and continuous hypoxia, after 1 day, 3 days, 7 days and 30 days, mRNA levels of corticotropin-releasing hormone (CRH) and growth hormone releasing hormone (GHRH) in hypothalamus of rats were detected using RT-PCR, and the levels of CRH, GHRH, corticotropin(ACTH), cortex ketone, and growth hormone in plasma were measured.
RESULTSAfter 30 days, the CRH mRNA levels in rats hypothalamus which exposed to intermittent hypoxia were increased significantly than those exposed to continuous hypoxia as well as normal control but GHRH decreased, there was no difference between continuous hypoxia and normal control. After 1 day, 3 days, and 7 days, there was no difference between continuous hypoxia and intermittent hypoxia. After 30 days, the plasmic level of CRH,ACTH and cortex ketone increased, GHRH decreased and GH had no obvious change.
CONCLUSIONThe rats' HPA axis level increases and GHRH restrained with chronic intermittent hypoxia during sleep, feedback regulation disorders.
Animals ; Corticotropin-Releasing Hormone ; metabolism ; Growth Hormone ; metabolism ; Growth Hormone-Releasing Hormone ; metabolism ; Hypothalamo-Hypophyseal System ; Hypoxia ; Male ; Pituitary-Adrenal System ; Rats ; Rats, Wistar ; Sleep Apnea Syndromes ; metabolism
2.Diagnostic significance and considerations of growth hormone stimulation testing and insulin-like growth factor 1 in growth hormone deficiency.
Chinese Journal of Contemporary Pediatrics 2023;25(12):1193-1197
The growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis is an essential component of the hypothalamic-pituitary growth hormone axis and plays a crucial role in childhood growth and development. Disruptions and abnormalities in the GH/IGF-1 signaling pathway and its pathways typically manifest as short stature in children. Children with short stature often undergo GH stimulation testing and IGF-1 level measurements to differentiate growth hormone deficiency (GHD) from other causes of growth delay. This article aims to analyze and elucidate the values of GH stimulation testing and IGF-1 measurement, providing reference for the diagnosis of GHD in children.
Child
;
Humans
;
Growth Hormone/metabolism*
;
Insulin-Like Growth Factor I/metabolism*
;
Insulin-Like Peptides
;
Insulin-Like Growth Factor Binding Protein 3
;
Human Growth Hormone/metabolism*
;
Dwarfism, Pituitary/diagnosis*
3.Current Research on the Structure and Function of the Growth Hormone Releasing Hormone Receptor.
Journal of Korean Society of Endocrinology 2006;21(3):173-183
Growth hormone releasing hormone receptor (GHRH-R) is a family B1 G-protein coupled receptor found predominantly on pituitary somatotrophs. In the adults it is required for the normal synthesis and release of growth hormone (GH) from the pituitary. During development it is required for the normal proliferation and maturation of somatotrophs within the pituitary. Mutations of this receptor in mouse and man are associated with GH deficiency, short stature and pituitary hypoplasia. This signaling system plays important roles in growth and development, metabolism of muscle and fat, and is implicated in the regulation of cardiac and immune function, wound healing, tumor growth and the aging process. Current areas of active research discussed here include: studiesof the structure of the receptor binding site and its interaction with GHRH, alternative splice variants of the GHRH-R which appear to promote tumor proliferation, truncated receptor isoforms that act as dominant negative inhibitors of wild type receptor, and the unclear physiologic role of the GHRH system in birds and fishes.
Adult
;
Aging
;
Animals
;
Binding Sites
;
Birds
;
Fishes
;
Growth and Development
;
Growth Hormone*
;
Growth Hormone-Releasing Hormone*
;
GTP-Binding Proteins
;
Humans
;
Metabolism
;
Mice
;
Protein Isoforms
;
Somatotrophs
;
Wound Healing
4.A Sustained Release Human Growth Hormone (LB03002):Efficacy and Safety Following Six-month Treatment in Children with Growth Hormone Deficiency (GHD).
Duk Hee KIM ; Byung Churl LEE ; Jeh Hoon SHIN ; Sei Won YANG ; Han Wook YOO ; Dong Kyu JIN ; Cheol Woo KO ; Woo Yeong CHUNG ; Byung Kyu SUH ; Kee Hyoung LEE ; Hyun Joo KIM ; Hyi Jeong JI ; John KIM
Journal of Korean Society of Pediatric Endocrinology 2005;10(1):6-6
BACKGROUND: LB03002[somatropin(rDNA origin) for injectable suspension] is a sustained release formulation of human growth hormone to be administered by once-a-week subcutaneous injections. Less frequent administration could provide a considerable improvement on compliance and convenience. OBJECTIVE: To determine the efficacy and safety of a LB03002 administered in children with GHD once weekly for 6 months. DESIGN: Open-label, active-controlled, randomised, parallel group, phase II study. PATIENTS: A total of forty-two naive or previously treated, pre-pubertal children with GHD, confirmed by two different GH provocation tests, were randomised and received either LB03002(0.3 or 0.5 mg/kg/week) or Eutropin(TM)(daily rhGH, 0.3 mg/ kg/week divided 6 times a week) for 6 months. RESULTS: The pre-treatment(HV0) and 6-month annualised height velocity(HV6) are shown(mean+/-SD) in the table below: ----------------------------------------------------------------------- LB03002 LB03002 EutropinTM 0.3 mg/kg/week 0.5 mg/kg/week 0.3 mg/kg/week ----------------------------------------------------------------------- N 10 13 13 HV0 3.1+/-1.0 3.9+/-1.5 3.0+/-1.1 HV6 9.3+/-2.3 10.2+/-2.3 11.1+/-2.5 ----------------------------------------------------------------------- Mean IGF-I and IGFBP-3 levels were significantly elevated from baseline values in all the study groups. LB03002 at all dose groups was safe and well tolerated. No clinically relevant adverse events or abnormal laboratory parameters were observed and there were no remarkable differences between groups or changes over time within groups regarding parameters for glucose and lipid metabolism including fasting glucose and haemoglobin A1c. Injection site reactions were mostly mild to occasionally moderate and resolved within 2 to 3 days post-dose without intervention. CONCLUSIONS: Treatment with LB03002 by weekly administration of the doses tested in the study resulted in comparable safety and efficacy to daily rhGH in pre-pubertal children with GHD.
Child*
;
Compliance
;
Fasting
;
Glucose
;
Growth Hormone*
;
Human Growth Hormone*
;
Humans*
;
Injections, Subcutaneous
;
Insulin-Like Growth Factor Binding Protein 3
;
Insulin-Like Growth Factor I
;
Lipid Metabolism
5.The effects of liver disease on endocrine hormone.
Mengyuan YANG ; Bing LI ; Huiguo DING
Chinese Journal of Hepatology 2014;22(3):168-170
6.Relationship between levels of testosterone and cortisol in saliva and aggressive behaviors of adolescents.
Biomedical and Environmental Sciences 2009;22(1):44-49
OBJECTIVETo explore the endocrinal factors which influence the aggressive behavior of adolescents.
METHODSThe levels of cortisol (CORT), testosterone (T), prolactin (PRL), and growth hormone (GH) in saliva from 20 aggressive students and 20 non-aggressive control students were measured by radioimmunoassay (RIA). The students were matched for their gender, age, grade, stage of pubertal development, and economic status of their families.
RESULTSThe salivary T levels were 22.20 +/- 14.50 pg/mL and 19.54 +/- 12.52 pg/mL in aggressive male and female students, 13.20 +/- 6.85 pg/mL and 5.24 +/- 3.03 pg/mL in non-aggressive male and female students (P < 0.05). The male aggressive students had a lower level of CORT in saliva than non-aggressive male students (P < 0.05). There were no significant differences in the salivary levels of PRL or GH between the aggressive and non-aggressive groups. Correlation analysis revealed a negative relationship in male students between the salivary CORT levels and the aggression factor scores of the child behavior checklist (CBCL). In addition, the data also showed a positive relationship between the salivary T levels and the aggression factor scores of CBCL in female students. Multiple linear regression analysis showed that the salivary CORT level was an independent predictive factor for aggressive behaviors in adolescent boys. The higher the CORT level, the less aggressive the boys were.
CONCLUSIONCORT and T levels may play a certain role in adolescent aggressive behaviors.
Adolescent ; Aggression ; Child ; Female ; Growth Hormone ; metabolism ; Humans ; Hydrocortisone ; metabolism ; Male ; Prolactin ; metabolism ; Saliva ; metabolism ; Testosterone ; metabolism
7.Effect of F89 on body v levels of Gaoyou duck.
Yu-chuan ZHOU ; Yin-xue XU ; Ru qian ZHAO
Chinese Journal of Applied Physiology 2002;18(4):316-328
Animals
;
Benzodiazepines
;
pharmacology
;
Ducks
;
physiology
;
Growth Hormone
;
blood
;
Insulin-Like Growth Factor I
;
metabolism
;
Serum
;
metabolism
;
Weight Gain
;
drug effects
8.Research advances on common detection biomarkers and methodology of children's growth and development assessment.
Chinese Journal of Preventive Medicine 2022;56(9):1211-1217
With the rapid dissemination of information in modern society, Chinese residents pay more attention to the scientific concept of childcare, which makes the child prevention and health care industry develop rapidly. The law of children's growth and development is extremely complex, so it is necessary to detect different biomarkers according to different growth and development evaluation angles. Human growth hormone(hGH), insulin-like growth factor-1(IGF-1), insulin-like growth factor binding protein-3(IGFBP-3), thyroid hormone, sex hormone, anti-müllerian hormone(AMH) and 25-hydroxy vitamin D(25-OH VD) are common biomarkers to monitor children's growth and development. This article aims to explain the concept and characteristics of common biomarkers of growth and development, summarize the detection methods of common biomarkers of growth and development evaluation developed in recent years, and provide a reference for children's prevention and health care to select appropriate detection biomarkers.
Anti-Mullerian Hormone/metabolism*
;
Biomarkers
;
Child
;
Growth and Development
;
Human Growth Hormone/metabolism*
;
Humans
;
Insulin-Like Growth Factor Binding Protein 3
;
Insulin-Like Growth Factor I/metabolism*
;
Thyroid Hormones
;
Vitamin D
9.An assessment of androgenic/anti-androgenic effects of GH transgenic carp by Hershberger assay.
YuMei LIU ; WenZhong ZHANG ; Ling YONG ; XiaoHong ZHAO ; XuDong JIA ; Ning LI
Biomedical and Environmental Sciences 2011;24(4):445-449
OBJECTIVETo evaluate the androgenic and anti-androgenic effects of GH (growth hormone) transgenic carp in male rats.
METHODSHershberger assay was carried out in castrated male SD rats aged 4-5 weeks. Testosterone propionate (TP) (0.4 mg/kg BW) was administrated for a positive control, GH transgenic carp (3.0 g/kg BW)+TP (0.4 mg/kg BW), parental carp (3.0 g/kg BW) + TP (0.4 mg/kg BW), and flutamide (Flu) (3.0 g/kg BW) were used for negative controls, and vehicle was administered orally for a blank control. All groups were administrated for 10 consecutive days. At the end of the test, animals were anesthetized, then weights of accessory sex organ were measured. Serum testosterone (T), luteinizing hormone (LH), and Follicle-Stimulating Hormone (FSH) levels were detected.
RESULTSThe weights ratios of the accessory sex organs and body weights showed no significant differences between the solvent control and the GH transgenic carp-treated groups. Serum concentrations of FSH, LH, and T of the rats treated with GH transgenic carp + TP showed no significant changes, compared with those treated with TP only.
CONCLUSIONGH transgenic carp does not have any androgenic agonist or antagonist properties in vivo screening tests.
Animals ; Animals, Genetically Modified ; Carps ; genetics ; Follicle Stimulating Hormone ; blood ; Genitalia, Male ; drug effects ; Growth Hormone ; genetics ; metabolism ; pharmacology ; Luteinizing Hormone ; blood ; Male ; Rats ; Testosterone ; blood
10.Effects of growth hormone on glucose metabolism and insulin resistance in human.
Annals of Pediatric Endocrinology & Metabolism 2017;22(3):145-152
Growth hormone (GH) is important for promotion of somatic growth and the regulation of substrate metabolism. Metabolic action of GH occurs in multiple tissues including the liver, muscle, fat and pancreas either directly or indirectly through insulin-like growth factor 1. The diabetogenic action of GH has been well-described in previous in vivo studies. In this paper, we review the metabolic effects of GH on peripheral tissues focusing on glucose metabolism and insulin resistance, and discuss results from human studies on the long-term effects of GH administration on insulin resistance and hyperglycemia.
Glucose*
;
Growth Hormone*
;
Humans*
;
Hyperglycemia
;
Insulin Resistance*
;
Insulin*
;
Liver
;
Metabolism*
;
Pancreas